[Increase in New Approvals of Strong Opioid Medications in Switzerland].

Thalmann, Nicolas; Burgstaller, Jakob M.; Streitberger, Konrad; Baumgartner, Christine; Vorbrüggen, Meike; Wertli, Maria M. (2020). [Increase in New Approvals of Strong Opioid Medications in Switzerland]. Praxis, 109(15), pp. 1183-1187. Hogrefe 10.1024/1661-8157/a003565

[img] Text
Starker_Anstieg_der_Neuzulassungen_Praxis_Thalmann_2020.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (2MB)

Increase in New Approvals of Strong Opioid Medications in Switzerland Abstract. Consumption of pain medication, especially opioids, has risen sharply since 2000, both worldwide and in Switzerland. However, it is unknown whether this increased use is associated with an increase in new approvals of pain medications. An analysis of new approvals of painkillers in Switzerland showed a significant increase from the year 2000 onwards. The majority of new registrations were strong opioid preparations, while the trend in new registrations of non-opioid painkillers was decreasing. Furthermore, the treatment duration of newly approved strong opioids increased significantly from the year 2000 onwards, which may lead to a higher risk of overdoses or dependence.

Item Type:

 Journal Article (Original Article)

Division/Institute:

 04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology > Centre of Competence for Psychosomatic Medicine
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine
04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic and Policlinic for Anaesthesiology and Pain Therapy

UniBE Contributor:

 Streitberger, Konrad Markus, Baumgartner, Christine, Vorbrüggen, Meike, Wertli, Maria Monika

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 1661-8157

Publisher:

 Hogrefe

Language:

 German

Submitter:

 Jeannie Wurz

Date Deposited:

 05 Jan 2021 17:10

Last Modified:

 05 Dec 2022 15:43

Publisher DOI:

 10.1024/1661-8157/a003565

PubMed ID:

 33234039

Uncontrolled Keywords:

 Neuzulassungen Nicht-Opioide Nouvelles admissions Opioide Opioids Schmerzmedikamente analgésiques new approvals non-opioids non-opioïdes opioïdes pain medications

BORIS DOI:

 10.48350/150082

URI:

 https://boris.unibe.ch/id/eprint/150082

Actions (login required)

Edit item Edit item
Provide Feedback